REXCLAV 625
Amoxicillin & Potassium Clavulanate Tablets I.P.
Anti-infective
Schedule H Rx
Genuine RexCure Batch PackagingImage 1 of 2
REXCLAV 228.5
Amoxicillin & Potassium Clavulanate Oral Suspension IP
Standard-strength broad-spectrum pediatric antibacterial suspension for community-acquired childhood infections.
Strength
200 mg + 28.5 mg / 5 ml
Commercial Pack
Bottle (30 ml Reconstituted)
Indicative MRP
Rs. 69.21
Drug Class
Schedule H Rx
Active Chemical Composition
Each 5 ml suspension contains:
- Amoxicillin Trihydrate IP eq. to Amoxicillin 200 mg
- Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 28.5 mg
- Per 5 ml reconstituted
Primary Clinical Indications
1
Upper respiratory tract infections (tonsillitis, pharyngitis)
2
Mild to moderate otitis media in toddlers
3
Skin and urinary tract infections
Therapeutic Pharmacology & Overview
REXCLAV 228.5 provides broad-spectrum antibacterial coverage in a gentle lower-concentration presentation suitable for toddlers and younger pediatric cohorts.
Key Formulation Advantages
Synergistic amoxicillin-clavulanate protection against resistant bacteria
Lower concentration allows precise body-weight titration
Supplied with sterile reconstitution water
Child-friendly flavor eliminates administration distress
Dosage & Administration
Standard Adult / Pediatric Regimen:
As prescribed by pediatrician based on pediatric weight protocols.
Disclaimer: Dosage must be strictly adjusted by treating physicians based on clinical severity, renal clearance, and body weight.
Packaging & Storage Details
Commercial Presentation:
Amber glass bottle + sterile water ampoule + calibrated dosing cup
Storage Monograph:
Store dry powder in a cool, dry place. Reconstituted suspension must be refrigerated.
Market Authorization Holder:
RexCure Pharmaceuticals Pvt. Ltd.
Hyderabad, Telangana
Clinical Inquiry / Sample Request
Healthcare practitioners and hospital pharmacies may request detailed product dossiers, bio-equivalence data, or clinic samples.
Contact Medical DeskDrug Law Compliance
Marketed under Drugs and Cosmetics Act, 1940 and Rules thereunder. Distributed exclusively through licensed pharmaceutical wholesalers and pharmacies.Segment Portfolio
View Area (All) →Related Formulations in Anti-Infectives & Antibacterials
REXCLAV 457 DS
Amoxicillin & Potassium Clavulanate Oral Suspension IP (DS)